Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PTGES | O14684 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1884278 | 1.00 | CA1 (0.50) | CA1MGLLHDAC2NFE2L2HDAC1 | |
| SCHEMBL3381117 | 1.00 | CA1 (0.50) | CA1MGLLHDAC2NFE2L2HDAC1 | |
| SCHEMBL16657280 | 0.89 | APP (0.44) | CA1MGLLHDAC2NFE2L2HDAC1 | |
| SCHEMBL16657285 | 0.87 | APP (0.47) | CA1MGLLHDAC2HDAC1HDAC6 | |
| SCHEMBL13513154 | 0.86 | ALDH1A1 (0.46) | CA1MGLLHDAC2ALDH1A1NPC1 | |
| SCHEMBL27919608 | 0.85 | ALDH1A1 (0.56) | CA1MGLLACHEALDH1A1 | |
| SCHEMBL21435740 | 0.85 | ALDH1A1 (0.56) | CA1MGLLACHEALDH1A1 | |
| SCHEMBL21435722 | 0.85 | ALDH1A1 (0.56) | CA1MGLLACHEALDH1A1 | |
| SCHEMBL27367260 | 0.85 | ALDH1A1 (0.56) | CA1MGLLACHEALDH1A1 | |
| SCHEMBL9171323 | 0.85 | CA1 (0.62) | CA1MGLLHDAC2NFE2L2HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8420874-B2 | Stilbene derivative, light-emitting element, display apparatus, and electronic appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-04-16 | — | — | US | disclosed |
| US-20110204772-A1 | Stilbene Derivative, Light-Emitting Element, Display Apparatus, and Electronic Appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2011-08-25 | — | — | US | disclosed |
| US-7935854-B2 | 4,4'-bis[4-(10-phenyl-9-anthryl)phenyl]stilbene, having heat resistance which provides blue light emission | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-05-03 | — | — | US | disclosed |
| US-20080081934-A1 | Stilbene Derivative, Light-Emitting Element, Display Apparatus, and Electronic Appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081934-A1 | Stilbene Derivative, Light-Emitting Element, Display Apparatus, and Electronic Appliance | EED, HSPA1B, EPB41L2 | CA1 2742/4885MGLL 2963/4885HDAC2 234/4885 |
| US-20110204772-A1 | Stilbene Derivative, Light-Emitting Element, Display Apparatus, and Electronic Appliance | EED, HSPA1B, EPB41L2 | CA1 2742/4885MGLL 2963/4885HDAC2 234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.